A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors

Name: A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors
Published: 2013
License: Public Domain

ImmunoGen, Inc. · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

antibody egfr lung nsclc squamouscellcarcinoma

egfr positive solid tumors, imgn289, antibody drug conjugate, antibody, egfr, nsclc, scchn, head and neck, squamous cell carcinoma, solid tumor, immunogen, lung

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 982531
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.